CHDI Foundation
The CHDI Foundation, Inc., is a United States-based non-profit biomedical foundation that aims to "rapidly discover and develop drugs that delay or slow the progression of Huntington's disease", a neurodegenerative genetic disorder that affects muscle coordination and leads to cognitive decline. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for CHDI Foundation, United States, covering academic research published from 2007 to 2023. Read More.
Open Access Percentage
60%
Total
Publications
515
Total Open
Publications
311
Total
Citations
22K
Open Access
Percentage
60%
Total
Publications
515
Total Open
Publications
311
Total
Citations
22K
Breakdown
Publisher Open
8%
Both
33%
Other Platform Open
19%
Closed
40%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
90
Hybrid 36%
78
No Guarantees 22%
47
Other Platform Open
Domain 82%
220
Institution 42%
113
Preprint 14%
38
Public 13%
35
Other Internet 10%
27
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 221 |
Europe PMC | Domain | 143 |
University College London - UCL Discovery | Institution | 78 |
Semantic Scholar | Public | 29 |
bioRxiv | Preprint | 23 |
Cardiff University - ORCA Online Research @Cardiff | Institution | 19 |
University of Antwerp - Institutional Repository University of Antwerp | Institution | 18 |
DOI | Other Internet | 14 |
California Digital Library - eScholarship | Other Internet | 9 |
University of Cambridge - Apollo | Institution | 8 |